Veterinary Medicines

RAPIFAN 100 mg/ml SOLUCION INYECTABLE

Authorised
  • Menbutone
Download as PDF

Product identification

Medicine name:
RAPIFAN 100 mg/ml SOLUCION INYECTABLE
Active substance:
  • Menbutone
Target species:
  • Cattle
  • Sheep
  • Goat
  • Pig
  • Dog
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Menbutone
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        2
        day
    • Sheep
      • Meat and offal
        2
        day
    • Goat
      • Meat and offal
        2
        day
    • Pig
      • Meat and offal
        2
        day
    • Dog
    • Cattle
      • Milk
        2
        day
    • Sheep
      • Milk
        2
        day
    • Goat
      • Milk
        2
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        2
        day
    • Sheep
      • Meat and offal
        2
        day
    • Goat
      • Meat and offal
        2
        day
    • Horse
      • Meat and offal
        2
        day
    • Pig
      • Meat and offal
        2
        day
    • Dog
    • Cattle
      • Milk
        2
        day
    • Sheep
      • Milk
        2
        day
    • Goat
      • Milk
        2
        day
    • Horse
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA05AX90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 2565 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."